Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|
| Revenue | $0 | $247.4K | $208.2K | $876.4K |
| Cost of revenue | $958 | $202.8K | $94.8K | $392.0K |
| Gross profit | −$958 | $44.7K | $113.5K | $484.4K |
| Gross margin | — | 18.0% | 54.5% | 55.3% |
| R&D | $5.6K | $0 | $0 | $0 |
| Operating income | −$126.2K | −$41.2K | −$42.5K | −$511.5K |
| EBITDA | −$125.3K | −$41.2K | −$42.5K | −$511.5K |
| Net income | −$126.2K | −$41.2K | −$42.5K | −$511.6K |
| Net margin | — | -16.6% | -20.4% | -58.4% |
| EPS (diluted) | -0.00 | -0.00 | -0.00 | -0.00 |
Annual figures · source: Financial Modeling Prep
PROFILE SOLUTIONS INC
No one on the platform currently holds PSIQ.
No tracked institution reports a position in PSIQ as of their last filing.
| Execution date | Ratio |
|---|---|
| 2013-01-22 | 5-for-1 |
No one on the platform has traded PSIQ yet.
| +0.00% |
| $2M |
| — |
| MAYNFMayne Pharma Group Limited | $1.65 | +0.00% | $134M | — |
| OPORFhVIVO plc | $0.11 | +0.00% | $75M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.